Skip to Main Content

Boby Mathew

Associate Research Scientist

About

Titles

Associate Research Scientist

Appointments

Other Departments & Organizations

Research

Research at a Glance

Yale Co-Authors

Frequent collaborators of Boby Mathew's published research.

Publications

2026

  • Beta cell-derived cholecystokinin drives obesity-associated pancreatic adenocarcinoma development
    Garcia CC, Venkat A, McQuaid DC, Agabiti SS, Tong A, Mathew B, Cardone RL, Starble R, Ruiz CF, Zheng C, Sogunro A, Jacox JB, Loh KH, Kibbey RG, Krishnaswamy S, Muzumdar MD. Beta cell-derived cholecystokinin drives obesity-associated pancreatic adenocarcinoma development. Nature Communications 2026 DOI: 10.1038/s41467-026-69821-2.
    Peer-Reviewed Original Research
    This study investigates how beta cell-derived cholecystokinin drives obesity-associated pancreatic cancer development, showing that targeting endocrine signaling could prevent tumor progression in obesity-related contexts.
  • Beta cell-derived cholecystokinin drives obesity-associated pancreatic adenocarcinoma development
    Garcia C, Venkat A, McQuaid D, Agabiti S, Tong A, Mathew B, Cardone R, Starble R, Ruiz C, Zheng C, Sogunro A, Jacox J, Loh K, Kibbey R, Krishnaswamy S, Muzumdar M. Beta cell-derived cholecystokinin drives obesity-associated pancreatic adenocarcinoma development. Nature Communications 2026, 17: 3292. PMID: 41760660, PMCID: PMC13066563, DOI: 10.1038/s41467-026-69821-2.
    Peer-Reviewed Original Research
    This study investigates how obesity-induced cholecystokinin (CCK) expression in pancreatic beta cells drives pancreatic cancer development by altering cellular signaling within the environment of arising tumors, suggesting potential therapeutic targets.

2022

2021

Get In Touch